Vanguard Reports 0 Shares of Eastman Chemical
Eastman Chemical Co — Schedule 13G/A (Amendment No. 17) The Vanguard Group reports no beneficial ownership of Eastman Chemical Co. common stock, listing 0 shares and 0% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Eastman Chemical Co — Schedule 13G/A (Amendment No. 17)
The Vanguard Group reports no beneficial ownership of Eastman Chemical Co. common stock, listing 0 shares and 0% of the class. The filing explains that, following an internal realignment on January 12, 2026, certain Vanguard subsidiaries will report separately in reliance on SEC Release No. 34-39538.
Insights
Vanguard reports zero holdings after organizational realignment.
The filing states The Vanguard Group beneficially owns 0 shares of Eastman Chemical Co., representing 0% of the class. It attributes the change to an internal realignment effective January 12, 2026, with subsidiaries reporting disaggregated positions under SEC Release No. 34-39538.
Cash‑flow treatment and any prior holdings are not disclosed in the excerpt; subsequent filings by Vanguard subsidiaries may show redistributed positions. Regulatory reliance and the disaggregation statement are explicit in the text.
AI-generated analysis. How Rhea-AI works. Not financial advice.